2005
DOI: 10.1016/j.bcp.2004.12.018
|View full text |Cite
|
Sign up to set email alerts
|

Dual effects of acetylsalicylic acid on mast cell degranulation, expression of cyclooxygenase-2 and release of pro-inflammatory cytokines

Abstract: Several studies have demonstrated that nonsteroidal anti-inflammatory drugs, such as acetylsalicylic acid (ASA), can have inhibitory or enhancing effects on inflammatory cell function. These effects seem independent of cyclooxygenase activity and prostaglandin synthesis inhibition. Here, we examined the effect of ASA on bone marrow-derived mast cells in more detail. ASA blocked the expression of cyclooxygenase-2, the production of tumor necrosis factor-a and interleukin-6, and the release of granule mediators … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
29
0
1

Year Published

2007
2007
2015
2015

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 35 publications
(31 citation statements)
references
References 39 publications
1
29
0
1
Order By: Relevance
“…This indicates that the mechanisms of NSAID idiosyncrasy may also be underlying changes in the gastrointestinal barrier postulated in cofactor-induced anaphylaxis. In addition to these effects, in vitro pretreatment of mast cells with ASA directly modulated FceRI-dependent mast cell degranulation and LTC4 release following FceRI stimulation (44,45). Moreover, several studies could show that also in humans, systemic administration of ASA triggers increased skin test reactions to different allergens (30,32), supporting the concept that ASA next to modulating the intestinal absorption of allergens also directly modulates effector cell function in cofactor-induced anaphylaxis.…”
Section: Nsaidmentioning
confidence: 82%
“…This indicates that the mechanisms of NSAID idiosyncrasy may also be underlying changes in the gastrointestinal barrier postulated in cofactor-induced anaphylaxis. In addition to these effects, in vitro pretreatment of mast cells with ASA directly modulated FceRI-dependent mast cell degranulation and LTC4 release following FceRI stimulation (44,45). Moreover, several studies could show that also in humans, systemic administration of ASA triggers increased skin test reactions to different allergens (30,32), supporting the concept that ASA next to modulating the intestinal absorption of allergens also directly modulates effector cell function in cofactor-induced anaphylaxis.…”
Section: Nsaidmentioning
confidence: 82%
“…Since NSAIDs inhibit the production of cytokines from lymphocytes [2,3,4], they are also used as immunomodulatory drugs [5,6]. However, in some situations, such as in food-dependent exercise-induced anaphylaxis (FDEIA) [7,8], salicylate and its acetyl derivative, aspirin, can stimulate chemokine release from mast cells, triggering adverse immunological reactions [9,10]. On the other hand, chlorpromazine, one of the most traditionally used antipsychotic drugs [11], has also been recognized as an anti-allergic agent, because it inhibits histamine release from mast cells [12,13].…”
Section: Introductionmentioning
confidence: 99%
“…Via the prostaglandins' modulation of the activity of the HPA axis at the level of the hypothalamus, pituitary, and adrenal cortex [1,[35][36][37][38] , it can be hypothesized that ASA may lead to a suppression of stress-related HPA axis responses. Likewise, downregulation of cytokine production and secretion by ASA [39][40][41][42][43] might lead to reduced HPA axis activity, since proinflammatory cytokines are potent stimulators of corticotropin-releasing hormone (CRH) and thus HPA axis activity [3,38] .…”
Section: Introductionmentioning
confidence: 99%